A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma

Cancer Cell

Volumn 21, Issue 2, 2012, Pages 168-180

  Kawauchi, Daisuke ^a   Robinson, Giles ^a   Uziel, Tamar ^a,b   Gibson, Paul ^a   Rehg, Jerold ^a   Gao, Cuilan ^a   Finkelstein, David ^a   Qu, Chunxu ^a   Pounds, Stanley ^a   Ellison, David W ^a   Gilbertson, Richard J ^a   Roussel, Martine F ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN P53; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; CLINICAL FEATURE; CONTROLLED STUDY; IN VITRO GENE TRANSFER; MEDULLOBLASTOMA; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL;

ERINACEIDAE;

EID: 84857013044     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2011.12.023     Document Type: Article

References (61)

1. Aldosari N., Bigner S.H., Burger P.C., Becker L., Kepner J.L., Friedman H.S., McLendon R.E. MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence insitu hybridization study on paraffin sections from the Children's Oncology Group. Arch. Pathol. Lab. Med. 2002, 126:540-544.
2. Ayrault O., Zhao H., Zindy F., Qu C., Sherr C.J., Roussel M.F. Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells. Cancer Res. 2010, 70:5618-5627.
3. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
4. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., Weinberg R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 2008, 40:499-507.
5. Berman D.M., Karhadkar S.S., Hallahan A.R., Pritchard J.I., Eberhart C.G., Watkins D.N., Chen J.K., Cooper M.K., Taipale J., Olson J.M., Beachy P.A. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 2002, 297:1559-1561.
6. Blackwood E.M., Eisenman R.N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 1991, 251:1211-1217.
7. Bruggeman S.W., Valk-Lingbeek M.E., van der Stoop P.P., Jacobs J.J., Kieboom K., Tanger E., Hulsman D., Leung C., Arsenijevic Y., Marino S., van Lohuizen M. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev. 2005, 19:1438-1443.
8. Cho Y.J., Tsherniak A., Tamayo P., Santagata S., Ligon A., Greulich H., Berhoukim R., Amani V., Goumnerova L., Eberhart C.G., et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J.Clin. Oncol. 2011, 29:1424-1430.
9. Curley M.D., Therrien V.A., Cummings C.L., Sergent P.A., Koulouris C.R., Friel A.M., Roberts D.J., Seiden M.V., Scadden D.T., Rueda B.R., Foster R. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 2009, 27:2875-2883.
10. Eischen C.M., Weber J.D., Roussel M.F., Sherr C.J., Cleveland J.L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 1999, 13:2658-2669.
11. Ellison D.W., Onilude O.E., Lindsey J.C., Lusher M.E., Weston C.L., Taylor R.E., Pearson A.D., Clifford S.C. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J.Clin. Oncol. 2005, 23:7951-7957. United Kingdom Children's Cancer Study Group Brain Tumour Committee.
12. Ellison D.W., Dalton J., Kocak M., Nicholson S.L., Fraga C., Neale G., Kenney A.M., Brat D.J., Perry A., Yong W.H., et al. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol. 2011, 121:381-396.
13. Ellison D.W., Kocak M., Dalton J., Megahed H., Lusher M.E., Ryan S.L., Zhao W., Nicholson S.L., Taylor R.E., Bailey S., Clifford S.C. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J.Clin. Oncol. 2011, 29:1400-1407.
14. Frank A.J., Hernan R., Hollander A., Lindsey J.C., Lusher M.E., Fuller C.E., Clifford S.C., Gilbertson R.J. The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma. Brain Res. Mol. Brain Res. 2004, 121:137-140.
15. Gajjar A., Chintagumpala M., Ashley D., Kellie S., Kun L.E., Merchant T.E., Woo S., Wheeler G., Ahern V., Krasin M.J., et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006, 7:813-820.
16. Gibson P., Tong Y., Robinson G., Thompson M.C., Currle D.S., Eden C., Kranenburg T.A., Hogg T., Poppleton H., Martin J., et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 2010, 468:1095-1099.
17. Grandori C., Eisenman R.N. Myc target genes. Trends Biochem. Sci. 1997, 22:177-181.
18. Grandori C., Cowley S.M., James L.P., Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 2000, 16:653-699.
19. Hemann M.T., Bric A., Teruya-Feldstein J., Herbst A., Nilsson J.A., Cordon-Cardo C., Cleveland J.L., Tansey W.P., Lowe S.W. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 2005, 436:807-811.
20. Hermeking H., Eick D. Mediation of c-Myc-induced apoptosis by p53. Science 1994, 265:2091-2093.
21. Hoffman B., Liebermann D.A. Apoptotic signaling by c-MYC. Oncogene 2008, 27:6462-6472.
22. Johnson R.A., Wright K.D., Poppleton H., Mohankumar K.M., Finkelstein D., Pounds S.B., Rand V., Leary S.E., White E., Eden C., et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 2010, 466:632-636.
23. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997, 91:649-659.
24. Kenney A.M., Cole M.D., Rowitch D.H. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 2003, 130:15-28.
25. Kim J., Woo A.J., Chu J., Snow J.W., Fujiwara Y., Kim C.G., Cantor A.B., Orkin S.H. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010, 143:313-324.
26. Knoepfler P.S., Cheng P.F., Eisenman R.N. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 2002, 16:2699-2712.
27. Kool M., Koster J., Bunt J., Hasselt N.E., Lakeman A., van Sluis P., Troost D., Meeteren N.S., Caron H.N., Cloos J., et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE 2008, 3:e3088.
28. Lam C.W., Xie J., To K.F., Ng H.K., Lee K.C., Yuen N.W., Lim P.L., Chan L.Y., Tong S.F., McCormick F. A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 1999, 18:833-836.
29. Lee A., Kessler J.D., Read T.A., Kaiser C., Corbeil D., Huttner W.B., Johnson J.E., Wechsler-Reya R.J. Isolation of neural stem cells from the postnatal cerebellum. Nat. Neurosci. 2005, 8:723-729.
30. Lee Y., Miller H.L., Jensen P., Hernan R., Connelly M., Wetmore C., Zindy F., Roussel M.F., Curran T., Gilbertson R.J., McKinnon P.J. A molecular fingerprint for medulloblastoma. Cancer Res. 2003, 63:5428-5437.
31. Lumpkin E.A., Collisson T., Parab P., Omer-Abdalla A., Haeberle H., Chen P., Doetzlhofer A., White P., Groves A., Segil N., Johnson J.E. Math1-driven GFP expression in the developing nervous system of transgenic mice. Gene Expr. Patterns 2003, 3:389-395.
32. Malynn B.A., de Alboran I.M., O'Hagan R.C., Bronson R., Davidson L., DePinho R.A., Alt F.W. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 2000, 14:1390-1399.
33. McManamy C.S., Lamont J.M., Taylor R.E., Cole M., Pearson A.D., Clifford S.C., Ellison D.W. Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. J.Neuropathol. Exp. Neurol. 2003, 62:627-632. United Kingdom Children's Cancer Study Group.
34. Northcott P.A., Korshunov A., Witt H., Hielscher T., Eberhart C.G., Mack S., Bouffet E., Clifford S.C., Hawkins C.E., French P., et al. Medulloblastoma comprises four distinct molecular variants. J.Clin. Oncol. 2011, 29:1408-1414.
35. Pfaff E., Remke M., Sturm D., Benner A., Witt H., Milde T., von Bueren A.O., Wittmann A., Schöttler A., Jorch N., et al. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J.Clin. Oncol. 2010, 28:5188-5196.
36. Pfister S., Remke M., Benner A., Mendrzyk F., Toedt G., Felsberg J., Wittmann A., Devens F., Gerber N.U., Joos S., et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J.Clin. Oncol. 2009, 27:1627-1636.
37. Raffel C., Jenkins R.B., Frederick L., Hebrink D., Alderete B., Fults D.W., James C.D. Sporadic medulloblastomas contain PTCH mutations. Cancer Res. 1997, 57:842-845.
38. Read T.A., Fogarty M.P., Markant S.L., McLendon R.E., Wei Z., Ellison D.W., Febbo P.G., Wechsler-Reya R.J. Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell 2009, 15:135-147.
39. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
40. Rich J.N. Brain Tumor Stem Cell Markers 2009, Humana Press, New York.
41. Rios I., Alvarez-Rodríguez R., Martí E., Pons S. Bmp2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling. Development 2004, 131:3159-3168.
42. Romer J.T., Kimura H., Magdaleno S., Sasai K., Fuller C., Baines H., Connelly M., Stewart C.F., Gould S., Rubin L.L., Curran T. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 2004, 6:229-240.
43. Roussel M.F., Hatten M.E. Cerebellum development and medulloblastoma. Curr. Top. Dev. Biol. 2011, 94:235-282.
44. Schüller U., Heine V.M., Mao J., Kho A.T., Dillon A.K., Han Y.G., Huillard E., Sun T., Ligon A.H., Qian Y., et al. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 2008, 14:123-134.
45. Silva J., Smith A. Capturing pluripotency. Cell 2008, 132:532-536.
46. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
47. Swartling F.J., Grimmer M.R., Hackett C.S., Northcott P.A., Fan Q.W., Goldenberg D.D., Lau J., Masic S., Nguyen K., Yakovenko S., et al. Pleiotropic role for MYCN in medulloblastoma. Genes Dev. 2010, 24:1059-1072.
48. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
49. Taylor M.D., Poppleton H., Fuller C., Su X., Liu Y., Jensen P., Magdaleno S., Dalton J., Calabrese C., Board J., et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005, 8:323-335.
50. Thompson M.C., Fuller C., Hogg T.L., Dalton J., Finkelstein D., Lau C.C., Chintagumpala M., Adesina A., Ashley D.M., Kellie S.J., et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J.Clin. Oncol. 2006, 24:1924-1931.
51. Todaro M., Francipane M.G., Medema J.P., Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010, 138:2151-2162.
52. Uziel T., Zindy F., Xie S., Lee Y., Forget A., Magdaleno S., Rehg J.E., Calabrese C., Solecki D., Eberhart C.G., et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev. 2005, 19:2656-2667.
53. Wagner A.J., Kokontis J.M., Hay N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 1994, 8:2817-2830.
54. Wetmore C., Eberhart D.E., Curran T. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res. 2001, 61:513-516.
55. Wu X., Northcott P.A., Croul S., Taylor M.D. Mouse models of medulloblastoma. Chin J Cancer 2011, 30:442-449.
56. Yang Z.J., Ellis T., Markant S.L., Read T.A., Kessler J.D., Bourboulas M., Schüller U., Machold R., Fishell G., Rowitch D.H., et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008, 14:135-145.
57. Zhao H., Ayrault O., Zindy F., Kim J.H., Roussel M.F. Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development. Genes Dev. 2008, 22:722-727.
58. Zhu L., Gibson P., Currle D.S., Tong Y., Richardson R.J., Bayazitov I.T., Poppleton H., Zakharenko S., Ellison D.W., Gilbertson R.J. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009, 457:603-607.
59. Zindy F., Eischen C.M., Randle D.H., Kamijo T., Cleveland J.L., Sherr C.J., Roussel M.F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 1998, 12:2424-2433.
60. Zindy F., Knoepfler P.S., Xie S., Sherr C.J., Eisenman R.N., Roussel M.F. N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development. Proc. Natl. Acad. Sci. USA 2006, 103:11579-11583.
61. Zindy F., Uziel T., Ayrault O., Calabrese C., Valentine M., Rehg J.E., Gilbertson R.J., Sherr C.J., Roussel M.F. Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors. Cancer Res. 2007, 67:2676-2684.